BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1051 related articles for article (PubMed ID: 15767663)

  • 1. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.
    Wang X; Beugnet A; Murakami M; Yamanaka S; Proud CG
    Mol Cell Biol; 2005 Apr; 25(7):2558-72. PubMed ID: 15767663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a conserved motif required for mTOR signaling.
    Schalm SS; Blenis J
    Curr Biol; 2002 Apr; 12(8):632-9. PubMed ID: 11967149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function.
    Schalm SS; Fingar DC; Sabatini DM; Blenis J
    Curr Biol; 2003 May; 13(10):797-806. PubMed ID: 12747827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target of rapamycin (TOR)-signaling and RAIP motifs play distinct roles in the mammalian TOR-dependent phosphorylation of initiation factor 4E-binding protein 1.
    Beugnet A; Wang X; Proud CG
    J Biol Chem; 2003 Oct; 278(42):40717-22. PubMed ID: 12912989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation dynamics of eukaryotic initiation factor 4E binding protein 1 (4E-BP1) is discordant with its potential to interact with eukaryotic initiation factor 4E (eIF4E).
    Showkat M; Beigh MA; Bhat BB; Batool A; Andrabi KI
    Cell Signal; 2014 Oct; 26(10):2117-21. PubMed ID: 24975846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability.
    Beugnet A; Tee AR; Taylor PM; Proud CG
    Biochem J; 2003 Jun; 372(Pt 2):555-66. PubMed ID: 12611592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle.
    Lang CH; Frost RA
    J Cell Physiol; 2005 Apr; 203(1):144-55. PubMed ID: 15389631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of cell-signaling pathways in the regulation of mammalian target of rapamycin (mTOR) by amino acids in rat adipocytes.
    Pham PT; Heydrick SJ; Fox HL; Kimball SR; Jefferson LS; Lynch CJ
    J Cell Biochem; 2000 Sep; 79(3):427-41. PubMed ID: 10972980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism.
    Gingras AC; Gygi SP; Raught B; Polakiewicz RD; Abraham RT; Hoekstra MF; Aebersold R; Sonenberg N
    Genes Dev; 1999 Jun; 13(11):1422-37. PubMed ID: 10364159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTOR-mediated regulation of translation factors by amino acids.
    Proud CG
    Biochem Biophys Res Commun; 2004 Jan; 313(2):429-36. PubMed ID: 14684180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells.
    Bishop JD; Nien WL; Dauphinee SM; Too CK
    J Endocrinol; 2006 Aug; 190(2):307-12. PubMed ID: 16899564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different roles for the TOS and RAIP motifs of the translational regulator protein 4E-BP1 in the association with raptor and phosphorylation by mTOR in the regulation of cell size.
    Eguchi S; Tokunaga C; Hidayat S; Oshiro N; Yoshino K; Kikkawa U; Yonezawa K
    Genes Cells; 2006 Jul; 11(7):757-66. PubMed ID: 16824195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E.
    Fingar DC; Salama S; Tsou C; Harlow E; Blenis J
    Genes Dev; 2002 Jun; 16(12):1472-87. PubMed ID: 12080086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-stimulated kinase from rat fat cells that phosphorylates initiation factor 4E-binding protein 1 on the rapamycin-insensitive site (serine-111).
    Heesom KJ; Avison MB; Diggle TA; Denton RM
    Biochem J; 1998 Nov; 336 ( Pt 1)(Pt 1):39-48. PubMed ID: 9806882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
    Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
    Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.
    Tee AR; Fingar DC; Manning BD; Kwiatkowski DJ; Cantley LC; Blenis J
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13571-6. PubMed ID: 12271141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1.
    El-Chaâr D; Gagnon A; Sorisky A
    Int J Obes Relat Metab Disord; 2004 Feb; 28(2):191-8. PubMed ID: 14970836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism.
    Hara K; Yonezawa K; Weng QP; Kozlowski MT; Belham C; Avruch J
    J Biol Chem; 1998 Jun; 273(23):14484-94. PubMed ID: 9603962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
    Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
    Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4E-binding protein phosphorylation and eukaryotic initiation factor-4E release are required for airway smooth muscle hypertrophy.
    Zhou L; Goldsmith AM; Bentley JK; Jia Y; Rodriguez ML; Abe MK; Fingar DC; Hershenson MB
    Am J Respir Cell Mol Biol; 2005 Aug; 33(2):195-202. PubMed ID: 15901615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.